Literature DB >> 12151430

Ovarian response and pregnancy outcome related to mid-follicular LH levels in women undergoing assisted reproduction with GnRH agonist down-regulation and recombinant FSH stimulation.

P Humaidan1, L Bungum, M Bungum, C Yding Andersen.   

Abstract

BACKGROUND: The effect of LH levels on stimulation day 8 on ovarian response and pregnancy outcome were evaluated in women receiving pituitary down-regulation with GnRH agonists (0.8 mg Suprefact) s.c. daily until pituitary down-regulation and 0.4 mg/day during ovarian stimulation) and ovarian stimulation with recombinant FSH.
METHODS: Blood samples were prospectively collected from a total of 207 normal women undergoing assisted reproduction and analysed retrospectively. Based on LH levels on stimulation day 8 patients were divided into four groups: <0.5, 0.51-1.0, 1.01-1.5, >1.51 IU/l.
RESULTS: Estradiol levels on day 8 and estradiol per oocyte retrieved showed a highly significant correlation with LH concentrations on day 8. The total consumption of exogenous FSH and duration of gonadotrophin stimulation was inversely related to LH levels on day 8 (P < 0.002). The frequencies of fertilization and clinical pregnancies were superior in the two middle groups. Only 12% of the patients showed LH levels <0.5 IU/l, which, however, may be explained by the particular mode and doses of GnRH agonist used.
CONCLUSIONS: Circulating levels of LH on day 8 have a significant impact on ovarian response and pregnancy outcome. LH should neither be too high nor too low. The mode of administration and the dose of the GnRH agonist used may determine the number of women who experience LH levels below 0.5 IU/l.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12151430     DOI: 10.1093/humrep/17.8.2016

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  26 in total

1.  The effect of rLH supplementation to the GnRH-antagonist protocol on endocrine dynamics in the advanced reproductive age.

Authors:  J S Younis; I Izhaki; M Ben-Ami
Journal:  J Endocrinol Invest       Date:  2017-03-13       Impact factor: 4.256

2.  Differences in serum LH and FSH levels using depot or daily GnRH agonists in controlled ovarian stimulation: influence on ovarian response and outcome of ART.

Authors:  Barbara Sonntag; Ludwig Kiesel; Eberhard Nieschlag; Hermann M Behre
Journal:  J Assist Reprod Genet       Date:  2005-08       Impact factor: 3.412

3.  Effects of Low Luteinizing Hormone During Ovarian Stimulation on Endometrial Gene Expression and Function - Transcriptome Analysis During the Implantation Window.

Authors:  Shuo Han; Ming-Hui Liu; Ya-Su Lv; Hai-Ying Ren; Jing Guo; Yuan Li; Shan Liu
Journal:  Reprod Sci       Date:  2022-02-15       Impact factor: 3.060

Review 4.  Contemporary pharmacological manipulation in assisted reproduction.

Authors:  Judith A F Huirne; Cornelis B Lambalk; Andre C D van Loenen; Roel Schats; Peter G A Hompes; Bart C J M Fauser; Nick S Macklon
Journal:  Drugs       Date:  2004       Impact factor: 9.546

5.  A modified ultra-long pituitary downregulation protocol improved endometrial receptivity and clinical outcome for infertile patients with polycystic ovarian syndrome.

Authors:  Fei Gong; Xihong Li; Shunji Zhang; Hainan Ma; Sufen Cai; Juan Li; G E Lin; Guangxiu Lu
Journal:  Exp Ther Med       Date:  2015-09-23       Impact factor: 2.447

6.  The ratio of late-follicular to mid-follicular phase LH concentrations efficiently predicts ART outcomes in women undergoing ART treatment with GnRH-agonist long protocol and stimulation with recombinant FSH.

Authors:  Koji Nakagawa; Shirei Ohgi; Akira Nakashima; Takashi Horikawa; Rikikazu Sugiyama; Hidekazu Saito
Journal:  J Assist Reprod Genet       Date:  2008-08-28       Impact factor: 3.412

7.  Reduced FSH and LH action: implications for medically assisted reproduction.

Authors:  E Bosch; C Alviggi; M Lispi; A Conforti; A C Hanyaloglu; D Chuderland; M Simoni; N Raine-Fenning; P Crépieux; S Kol; V Rochira; T D'Hooghe; P Humaidan
Journal:  Hum Reprod       Date:  2021-05-17       Impact factor: 6.918

8.  Clinical outcome of one-third-dose depot triptorelin is the same as half-dose depot triptorelin in the long protocol of controlled ovarian stimulation.

Authors:  Yu Li; Dongzi Yang; Qingxue Zhang
Journal:  J Hum Reprod Sci       Date:  2012-01

9.  Live-birth rates after HP-hMG stimulation in the long GnRH agonist protocol: association with mid-follicular hCG and progesterone concentrations, but not with LH concentrations.

Authors:  Joan-Carles Arce; Johan Smitz
Journal:  Gynecol Endocrinol       Date:  2012-07-19       Impact factor: 2.260

10.  Combination of recombinant follicle stimulating hormone with human menopausal gonadotrophin or recombinant luteinizing hormone in a long gonadotrophin-releasing hormone agonist protocol: a retrospective study.

Authors:  Gottumukkala Achyuta Rama Raju; S C Teng; Prathigudupu Kavitha; Balabomma Kavitha Lakshmi; Cheemakurthi Ravikrishna
Journal:  Reprod Med Biol       Date:  2012-02-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.